Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
about
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infectionSystematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionFacing resistance of H.pylori infectionTreatment of Helicobacter pylori infection: Past, present and futureTailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-AnalysisCurrent recommendations for Helicobacter pylori therapies in a world of evolving resistance.Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype.Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants.Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.High Helicobacter pylori cure rate with sitafloxacin-based triple therapy.Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trial.Resistance mechanisms of Helicobacter pylori and its dual target precise therapy.GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea.Seven-day genotypic resistance-guided triple Helicobacter pylori eradication therapy can be highly effective.Response to: Comment on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin".Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
P2860
Q26745727-EFEE8A7D-42D9-40F8-A361-231F3E192C2DQ26853010-483E97CD-ADB8-4929-AC8F-20D3BF96E2F7Q33596218-02FDC512-DE72-4727-9CAC-A23B133097A0Q34508830-C053D875-82CA-4BEB-BA0E-F512269EB3C4Q37206124-4DB10D40-E9D7-4688-8F7F-7370BB7D24F3Q37591509-CB9AC6A4-9720-441C-ACDE-4EA5F2A2790BQ38212210-AB7065B3-BFA2-441B-9140-D33A4460E5FCQ38219028-7D1E20B2-A127-4894-AB32-77671A59BAB8Q38238745-90AE7132-4572-4717-A1AE-4B455AEFFB7BQ38462098-611D0C8D-ADFC-48F5-9367-BDBE0C327D1AQ38540311-88A77F16-0706-4F4F-9590-1FFCA3B7DB22Q39014381-6EDB0A76-CFFA-4FD7-ACE4-7B4B07B60D8FQ39496571-10668F39-71A3-4C4E-BFEF-E41AF4B6F95FQ39496596-CA1971AC-221F-4D13-8021-EE16A4FE56D5Q39496607-F4BA7224-E2D3-42D1-BEA3-24B769CFBBAFQ40198705-5FB2D358-EDB7-44BD-8309-29C6ADC2BD95Q41592572-954EE767-D77B-433E-882F-42C3425711CCQ43218781-29C784E9-A546-47CF-ADFA-9FA69696C2D6Q47672283-55AC358D-5F4F-45DA-B20E-57DA1D98F7C4Q52732728-40ED637C-F388-479A-B1CE-3FB0351D5253Q53273648-2A546372-24A6-4B6E-8BCA-3016793D3ACCQ54261794-3DB93F56-A7A8-4359-828C-AE5C7E48D848Q55345155-9721B9D0-3120-40CC-8932-60D4BE8678FDQ57226378-07BFAA9C-A264-4570-9FA2-34B5968F0DDA
P2860
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Tailored eradication therapy b ...... clarithromycin sensitivities.
@en
Tailored eradication therapy b ...... clarithromycin sensitivities.
@nl
type
label
Tailored eradication therapy b ...... clarithromycin sensitivities.
@en
Tailored eradication therapy b ...... clarithromycin sensitivities.
@nl
prefLabel
Tailored eradication therapy b ...... clarithromycin sensitivities.
@en
Tailored eradication therapy b ...... clarithromycin sensitivities.
@nl
P2093
P1476
Tailored eradication therapy b ...... clarithromycin sensitivities.
@en
P2093
Atsushi Sofuni
Emiko Rimbara
Fuminori Moriyasu
Kenji Yagi
Kohei Kawakami
Masanori Sasatsu
Mikinori Kataoka
Norihisa Noguchi
Takao Itoi
Takashi Kawai
P304
P356
10.1111/J.1440-1746.2008.05408.X
P478
23 Suppl 2
P577
2008-12-01T00:00:00Z